The analysis of miRNA signatures in PBMCs also revealed associations with autoantibodies in T1D patients, with increased levels of miR326 correlating with GAD and IA2 antibodies (66) and reduced levels of miR146a correlating with antibodies against GAD (56). Here, GAD1 is linked to type 1 diabetes mellitus.